Ann-cathrine Rylander-Jonsson
AstraZeneca R&D
Goeteborg, O, Sweden
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
SGLT2 inhibition improves coronary flow velocity reserve and contractility: role of glucagon signaling.
Journal: Cardiovascular diabetology
Published: July 30, 2024
l-α-Lysophosphatidylinositol (LPI) aggravates myocardial ischemia/reperfusion injury via a GPR55/ROCK-dependent pathway.
Journal: Pharmacology research & perspectives
Published: December 04, 2018
SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob-/- mice.
Journal: Cardiovascular diabetology
Published: October 04, 2018
The APOE∗3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis.
Journal: Journal of diabetes research
Published: July 12, 2018
In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR-/-ApoB100/100 mice.
Journal: Diabetes & vascular disease research
Published: March 04, 2018
Radial artery intima-media thickness regresses after secondary prevention interventions in patients' post-acute coronary syndrome and is associated with cardiac and kidney biomarkers.
Journal: Oncotarget
Published: December 28, 2016
Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability.
Journal: Science translational medicine
Published: December 21, 2016
The effects of dual PPARα/γ agonism compared with ACE inhibition in the BTBRob/ob mouse model of diabetes and diabetic nephropathy.
Journal: Physiological reports
Published: December 20, 2016
Hyperglycemia Induced by Glucokinase Deficiency Accelerates Atherosclerosis Development and Impairs Lesion Regression in Combined Heterozygous Glucokinase and the Apolipoprotein E-Knockout Mice.
Journal: Journal of diabetes research
Published: May 06, 2016
Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approaches.
Journal: Journal of diabetes research
Published: November 26, 2014
Last Updated: 09/26/2026